Abstract
Propose: This study was done to reduce atrophic vaginitis.
Aim: This study aimed to compare the effects of Vagiheal Gel and Estromarin in reducing atrophic vaginitis.
Methods: This study was a randomized clinical trial with a parallel design. 70 postmenopausal women who had dyspareunia and were referred to the health clinics of Arak, Iran were included in this study. Patients were assigned to one of the 2 groups of Vagiheal or Estromarin. The patients in the Estromarin group were provided with 0.625 mg/g vaginal cream for intravaginal use 2.5 grams for 21 nights. After one week of medicinal rest, they were prescribed 2.5 grams of intravaginal cream for another 21 nights, and then, one week of medicinal rest was considered. The patients in the Vagiheal group were prescribed 2.5 grams of Vagiheal Gel by inserting the applicator into the vagina when sleeping for 7 consecutive nights, then as a maintenance treatment for 2 times a week for 2 months. The severity of the symptoms was measured by a visual Analog scale (VAS) before, 2 weeks, 1 month, and 2 months after starting the program. The data were analyzed using T-test, Mann-Whitney, Chi-square, and Friedman test.
Results: The results of atrophic vaginitis follow-up processes showed that the mean of dryness, itching, and burning of the vagina in both groups significantly decreased after the intervention (p=0.01); however, the decrease of these symptoms in the dyspareunia group was more obvious in Vagiheal gel.
Conclusion: It seems that Vagiheal gel is a suitable alternative to atrophic vaginitis treatment.
Graphical Abstract
[1]
Ansari, N.; Vakilian, K.; Rezveh, F. Sexual health during menopause - counselling with an approach to emotional regulation on sexual satisfaction. Family Med. Primary Care Rev., 2019, 21(4), 318-323.
[http://dx.doi.org/10.5114/fmpcr.2019.90159]
[http://dx.doi.org/10.5114/fmpcr.2019.90159]
[2]
Shah, M.; Makwana, N.; Chaudhary, M. Vaginal pH as a diagnostic tool for menopause: A preliminary analysis. J Midlife Health, 2020, 11(3), 133-136.
[http://dx.doi.org/10.4103/jmh.JMH_1_20] [PMID: 33384535]
[http://dx.doi.org/10.4103/jmh.JMH_1_20] [PMID: 33384535]
[3]
Abbasinia, H.; Alizadeh, Z.; Vakilian, K.; Ranjbaran, M. Effect of chamomile extract on sleep disorder in menopausal women. Iran. J. Obstet. Gynecol. Infertil., 2016, 19(20), 1-7.
[4]
Mastroianni, J.; Thompson, J.A.; Shifren, J.L.; Zuckerman, A.L.; Pereira, K. Improving the identification of genitourinary syndrome of menopause through the utilization of the day-to-day impact of vaginal aging questionnaire. Menopause, 2020, 27(11), 1295-1301.
[http://dx.doi.org/10.1097/GME.0000000000001668] [PMID: 33110046]
[http://dx.doi.org/10.1097/GME.0000000000001668] [PMID: 33110046]
[5]
Palacios, S.; Combalia, J.; Emsellem, C.; Gaslain, Y.; Khorsandi, D. Therapies for the management of genitourinary syndrome of menopause. Post Reprod. Health, 2020, 26(1), 32-42.
[http://dx.doi.org/10.1177/2053369119866341] [PMID: 31387514]
[http://dx.doi.org/10.1177/2053369119866341] [PMID: 31387514]
[6]
Angelou, K.; Grigoriadis, T.; Diakosavvas, M.; Zacharakis, D.; Athanasiou, S. The genitourinary syndrome of menopause: An overview of the recent data. Cureus, 2020, 12(4), e7586.
[http://dx.doi.org/10.7759/cureus.7586] [PMID: 32399320]
[http://dx.doi.org/10.7759/cureus.7586] [PMID: 32399320]
[8]
Abedi, P.; Najafian, M.; Yaralizadeh, M.; Namjoyan, F. Effect of fennel vaginal cream on sexual function in postmenopausal women: A double blind randomized controlled trial. J. Med. Life, 2018, 11(1), 24-28.
[PMID: 29696061]
[PMID: 29696061]
[9]
Beyazit, F.; Sahin, B. Determining the factors influencing the intimate relationship between sexual satisfaction and dyadic adjustment in postmenopausal women. Menopause Rev., 2018, 17(2), 57-62.
[10]
Bae, J.M.; Yoon, B.K. The role of menopausal hormone therapy in reducing all-cause mortality in postmenopausal women younger than 60 years: An adaptive meta-analysis. J. Menopausal Med., 2018, 24(3), 139-142.
[http://dx.doi.org/10.6118/jmm.2018.24.3.139] [PMID: 30671404]
[http://dx.doi.org/10.6118/jmm.2018.24.3.139] [PMID: 30671404]
[11]
Yaralizadeh, M.; Abedi, P.; Najar, S.; Namjoyan, F.; Saki, A. Effect of Foeniculum vulgare (fennel) vaginal cream on vaginal atrophy in postmenopausal women: A double-blind randomized placebo-controlled trial. Maturitas, 2016, 84, 75-80.
[http://dx.doi.org/10.1016/j.maturitas.2015.11.005] [PMID: 26617271]
[http://dx.doi.org/10.1016/j.maturitas.2015.11.005] [PMID: 26617271]
[12]
Bosak, Z.; Iravani, M.; Moghimipour, E.; Haghighizadeh, M.H.; Jelodarian, P. Evaluation of the effect of chamomile vaginal gel on subjective symptoms of vaginal atrophy in postmenopausal women: A randomized clinical controlled trial. Iran. J. Obstet. Gynecol. Infertil., 2019, 22(7), 23-31.
[13]
Sadeghi, M.; Abbaspoor, Z.; Namjouyan, F.; Cheraghian, B. Effect of Glycyrrhiza glabra vaginal cream on the mental symptoms of vaginal atrophy in postmenopausal women. Iran. J. Obstet. Gynecol. Infertil., 2018, 21(4), 53-61.
[14]
Abdi, F.; Mobedi, H.; Roozbeh, N. Hops for menopausal vasomotor symptoms: Mechanisms of action. J. Menopausal Med., 2016, 22(2), 62-64.
[http://dx.doi.org/10.6118/jmm.2016.22.2.62] [PMID: 27617238]
[http://dx.doi.org/10.6118/jmm.2016.22.2.62] [PMID: 27617238]
[15]
Chadwick, L.R.; Pauli, G.F.; Farnsworth, N.R. The pharmacognosy of Humulus lupulus L. (hops) with an emphasis on estrogenic properties. Phytomedicine, 2006, 13(1-2), 119-131.
[http://dx.doi.org/10.1016/j.phymed.2004.07.006] [PMID: 16360942]
[http://dx.doi.org/10.1016/j.phymed.2004.07.006] [PMID: 16360942]
[16]
Harris, R.B.; Laws, A.; Reddy, V.M.; King, A.; Haskell, W.L. Are women using postmenopausal estrogens? A community survey. Am. J. Public Health, 1990, 80(10), 1266-1268.
[http://dx.doi.org/10.2105/AJPH.80.10.1266] [PMID: 2400044]
[http://dx.doi.org/10.2105/AJPH.80.10.1266] [PMID: 2400044]
[17]
Vakilian, K.; Alizadeh, Z.; Matouripour, P.; Abasinia, H. The effect of hypericum Perforatum (Perforan) on wound healing and pain of episiotomy. Iran. J. Obstet. Gynecol. Infertil., 2016, 18(180), 16-23.
[18]
Reich, A.; Heisig, M.; Phan, N.; Taneda, K.; Takamori, K.; Takeuchi, S.; Furue, M.; Blome, C.; Augustin, M.; Ständer, S.; Szepietowski, J. Visual analogue scale: Evaluation of the instrument for the assessment of pruritus. Acta Derm. Venereol., 2012, 92(5), 497-501.
[http://dx.doi.org/10.2340/00015555-1265] [PMID: 22102095]
[http://dx.doi.org/10.2340/00015555-1265] [PMID: 22102095]
[19]
Ekin, M.; Yaşar, L.; Savan, K.; Temur, M.; Uhri, M.; Gencer, I.; Kıvanç, E. The comparison of hyaluronic acid vaginal tablets with estradiol vaginal tablets in the treatment of atrophic vaginitis: A randomized controlled trial. Arch. Gynecol. Obstet., 2011, 283(3), 539-543.
[http://dx.doi.org/10.1007/s00404-010-1382-8] [PMID: 20135132]
[http://dx.doi.org/10.1007/s00404-010-1382-8] [PMID: 20135132]
[20]
Notelovitz, M.; Funk, S.; Nanavati, N.; Mazzeo, M. Estradiol absorption from vaginal tablets in postmenopausal women. Obstet. Gynecol., 2002, 99(4), 556-562.
[PMID: 12039110]
[PMID: 12039110]
[21]
Santen, R.J.; Mirkin, S.; Bernick, B.; Constantine, G.D. Systemic estradiol levels with low-dose vaginal estrogens. Menopause, 2020, 27(3), 361-370.
[http://dx.doi.org/10.1097/GME.0000000000001463] [PMID: 31794498]
[http://dx.doi.org/10.1097/GME.0000000000001463] [PMID: 31794498]
[22]
Villa, P.; Tagliaferri, V.; Amar, I.D.; Cipolla, C.; Ingravalle, F.; Scambia, G.; Ricciardi, W.; Lanzone, A. Local ultra-low-dose estriol gel treatment of vulvo-vaginal atrophy: Efficacy and safety of long-term treatment. Gynecol. Endocrinol., 2020, 36(6), 535-539.
[http://dx.doi.org/10.1080/09513590.2019.1702016] [PMID: 31847628]
[http://dx.doi.org/10.1080/09513590.2019.1702016] [PMID: 31847628]
[23]
Overk, C.R.; Guo, J.; Chadwick, L.R.; Lantvit, D.D.; Minassi, A.; Appendino, G.; Chen, S.N.; Lankin, D.C.; Farnsworth, N.R.; Pauli, G.F.; van Breemen, R.B.; Bolton, J.L. In vivo estrogenic comparisons of Trifolium pratense (red clover) Humulus lupulus (hops), and the pure compounds isoxanthohumol and 8-prenylnaringenin. Chem. Biol. Interact., 2008, 176(1), 30-39.
[http://dx.doi.org/10.1016/j.cbi.2008.06.005] [PMID: 18619951]
[http://dx.doi.org/10.1016/j.cbi.2008.06.005] [PMID: 18619951]
[24]
Nazarpour, S.; Simbar, M.; Ramezani Tehrani, F.; Alavi Majd, H. Quality of life and sexual function in postmenopausal women. J. Women Aging, 2018, 30(4), 299-309.
[http://dx.doi.org/10.1080/08952841.2017.1395539] [PMID: 29077541]
[http://dx.doi.org/10.1080/08952841.2017.1395539] [PMID: 29077541]
[25]
Najaf Najafi, M.; Ghazanfarpour, M. Effect of phytoestrogens on sexual function in menopausal women: A systematic review and meta-analysis. Climacteric, 2018, 21(5), 437-445.
[http://dx.doi.org/10.1080/13697137.2018.1472566] [PMID: 30156931]
[http://dx.doi.org/10.1080/13697137.2018.1472566] [PMID: 30156931]
[26]
Mazalzadeh, F.; Hekmat, K.; Namjoyan, F.A. SakiMalehi, Effect of fenugreek vaginal cream on dyspareunia and sexual satisfaction in menopausal women: A randomized clinical trial. Iran. J. Obstet. Gynecol. Infertil., 2018, 21(3), 22-30.
[27]
Bosak, Z.; Iravani, M.; Moghimipour, E.; Haghighizadeh, M.H.; Jelodarian, P.; Khazdair, M.R. Evaluation of the influence of chamomile vaginal gel on dyspareunia and sexual satisfaction in postmenopausal women: A randomized, double-blind, controlled clinical trial. Avicenna J. Phytomed., 2020, 10(5), 481-491.
[PMID: 32995326]
[PMID: 32995326]
[28]
Morali, G.; Polatti, F.; Metelitsa, E.N.; Mascarucci, P.; Magnani, P.; Marrè, G.B. Open, non-controlled clinical studies to assess the efficacy and safety of a medical device in form of gel topically and intravaginally used in postmenopausal women with genital atrophy. Arzneimittelforschung, 2006, 56(3), 230-238.
[PMID: 16618016]
[PMID: 16618016]
[29]
Dizavandi, F.R.; Ghazanfarpour, M.; Roozbeh, N.; Kargarfard, L.; Khadivzadeh, T.; Dashti, S. An overview of the phytoestrogen effect on vaginal health and dyspareunia in peri- and post-menopausal women. Post Reprod. Health, 2019, 25(1), 11-20.
[http://dx.doi.org/10.1177/2053369118823365] [PMID: 30786797]
[http://dx.doi.org/10.1177/2053369118823365] [PMID: 30786797]
[30]
Erkkola, R.; Vervarcke, S.; Vansteelandt, S.; Rompotti, P.; De Keukeleire, D.; Heyerick, A. A randomized, double-blind, placebo-controlled, cross-over pilot study on the use of a standardized hop extract to alleviate menopausal discomforts. Phytomedicine, 2010, 17(6), 389-396.
[http://dx.doi.org/10.1016/j.phymed.2010.01.007] [PMID: 20167461]
[http://dx.doi.org/10.1016/j.phymed.2010.01.007] [PMID: 20167461]
[31]
Heyerick, A.; Vervarcke, S.; Depypere, H.; Bracke, M.; Keukeleire, D.D. A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts. Maturitas, 2006, 54(2), 164-175.
[http://dx.doi.org/10.1016/j.maturitas.2005.10.005] [PMID: 16321485]
[http://dx.doi.org/10.1016/j.maturitas.2005.10.005] [PMID: 16321485]
